AUB ScholarWorks

Gemtuzumab Ozogamicin is a promising post-remission therapy for acute myeloid leukemia

Files in this item

Files Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)

Search AUB ScholarWorks


Browse

My Account